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Background: Few educational resources have been developed to inform patients’ renal replacement therapy (RRT)
selection decisions. Patients progressing toward end stage renal disease (ESRD) must decide among multiple
treatment options with varying characteristics. Complex information about treatments must be adequately
conveyed to patients with different educational backgrounds and informational needs. Decisions about treatment
options also require family input, as families often participate in patients’ treatment and support patients’ decisions.
We describe the development, design, and preliminary evaluation of an informational, evidence-based, and
patient-and family-centered decision aid for patients with ESRD and varying levels of health literacy, health
numeracy, and cognitive function.
Methods: We designed a decision aid comprising a complementary video and informational handbook. We based
our development process on data previously obtained from qualitative focus groups and systematic literature
reviews. We simultaneously developed the video and handbook in “stages.” For the video, stages included (1)
directed interviews with culturally appropriate patients and families and preliminary script development, (2) video
production, and (3) screening the video with patients and their families. For the handbook, stages comprised (1)
preliminary content design, (2) a mixed-methods pilot study among diverse patients to assess comprehension of
handbook material, and (3) screening the handbook with patients and their families.
Results: The video and handbook both addressed potential benefits and trade-offs of treatment selections. The
50-minute video consisted of demographically diverse patients and their families describing their positive and
negative experiences with selecting a treatment option. The video also incorporated health professionals’
testimonials regarding various considerations that might influence patients’ and families’ treatment selections. The
handbook was comprised of written words, pictures of patients and health care providers, and diagrams describing
the findings and quality of scientific studies comparing treatments. The handbook text was written at a 4th to 6th
grade reading level. Pilot study results demonstrated that a majority of patients could understand information
presented in the handbook. Patient and families screening the nearly completed video and handbook reviewed the
materials favorably.
Conclusions: This rigorously designed decision aid may help patients and families make informed decisions about
their treatment options for RRT that are well aligned with their values.
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Patients whose advanced chronic kidney disease (CKD) is
approaching end-stage renal disease (ESRD), or complete
kidney failure, face complex medical decision-making
regarding the type of medical therapy they wish to pursue.
Choices for treating ESRD are numerous and include
renal replacement therapies (RRTs) such as hemodialysis
delivered in a dialysis center three times per week, home
care dialysis (including peritoneal dialysis and home
hemodialysis, which patients administer to themselves
daily), and living or deceased kidney transplantation.
Patients may also choose to forgo RRT and instead opt for
conservative medical therapy (i.e., ongoing medical care
with their nephrologists to optimize health without dialy-
sis or kidney transplantation). Each treatment option has
different advantages, limitations, and implications for
survival, quality of life, financial stability, general health
status, and how patients experience their daily lives [1-3].
For instance, home dialysis therapies require patients’ sub-
stantial self-care and may afford patients more control
over their daily schedules, while in-center hemodialysis
requires less self-management but more frequent interface
with medical professionals and may offer patients less
autonomy [4]. Patients’ families are also impacted by RRT
decisions, as they often play substantial caregiver roles [5].
Despite patients’ critical need to understand the char-
acteristics of various RRTs to inform their treatment
decisions, many patients report having little to no gen-
eral awareness of what types of treatment options exist
for ESRD and many have little knowledge of treatment
risks and benefits prior to their initiation of RRT [2,5-9].
Patients’ poor access to adequate education about treat-
ments has been linked to their abrupt initiation of dialy-
sis and their suboptimal access to other forms of RRT,
[10,11] such as kidney transplantation, which is asso-
ciated with improved clinical outcomes [6,12-14]. A sub-
stantial proportion of patients with ESRD are elderly and
may have low educational attainment, poor health literacy
and numeracy, and cognitive decline associated with their
advancing kidney disease, heightening the challenges of
educating patients about their RRT choices [15-18].
Comprehensive decision aids are needed to help patients
with kidney disease and their families make informed RRT
selection decisions aligned with their personal values. This
paper describes our development of a patient-and-family
centered decision aid to inform RRT selection decisions.
Methods
Overarching goals, decision Aid content, and approach to
decision Aid design
Goals
We sought to develop a patient-and-family centered de-
cision aid (handbook and video) to help patients and
families choose among numerous RRT options. Wesought to ensure that the decision aid could be under-
stood by patients with a range of health literacy, health
numeracy, and cognitive needs. We used the 2006 Inter-
national Patient Decision Aids Standards (IPDAS) to
guide our development process [19]. All aspects of the
decision aid design, including the collection of primary
patient and family data to inform development, were
approved by the Johns Hopkins Medicine Institutional
Review Board.
Decision aid content
We intended for the decision aid to address both posi-
tive and negative features of treatment options that
patients (who had previously experienced treatments)
and their family members felt others making RRT deci-
sions should know about. We identified content to in-
clude via: (1) our own conduct of 20 focus groups of
patients and families identifying information they felt
should be included in decision aids guiding others’ RRT
selections (described elsewhere) [5] as well as our select-
ive review of qualitative studies published by other
investigators, [2,3,20] and (2) our conduct of rigorous
systematic literature reviews describing findings of scien-
tific studies comparing outcomes among patients select-
ing different RRTs (described elsewhere) [21-24]. Our
decision aid focused on seven key content areas or “con-
cerns” about treatments, including how treatments
might affect patients’: (1) morbidity and mortality
(“health problems”), (2) autonomy (“doing things”), (3)
treatment delivery (“how treatment works”), (4) symp-
toms (“symptoms”), (5) relationships (“relationships”),
(6) psychological well being (“feelings”), and (7) finances
(“money matters”) (Table 1).
Approach to designing the decision aid
We intended for the video and handbook to present
complementary subjective (in video) and evidence-based
(in handbook) information to a diverse English-speaking
audience. We developed the video and handbook simul-
taneously in three “stages” (Figure 1). We engaged a
multidisciplinary group of experts throughout the devel-
opment process, which included clinical experts (physi-
cians, social workers), an adult health education
specialist, a patient advocacy specialist, a video script-
writer, and a medical illustrator.
Methods: developing the video
We intended to provide patients and their families with
specific testimonials from others who had already made
treatment decisions. We attempted to ensure these testi-
monials addressed as many of the seven previously identi-
fied “concerns” as possible. When patients or families did
not address “concerns” in their testimonials, or if deemed
appropriate, we incorporated testimonials from health care
Table 1 Topics addressed in the decision aid
Concern Factor Video Handbook
Morbidity/
Mortality
Living longer
(“Health
Problems”)
Infections • •
Complications with surgery • •
Making frequent trips to the
doctor
•
Going to the hospital •
Autonomy (“Doing
Things”)
Doing things I want to do
when I want to do them
• •
Doing my usual activities • •
Freedom and control over
my life
• •
What I can eat or drink •
Control over my treatment
schedule
•
Going places by myself •
My quality of life • •
My social life • •
Ability to do things in my
free time
• •
How much free time I have • •
How I feel about traveling • •
Ability to go to work • •
What I can do at work •
How I feel about my work • •
My job and money • •
How free I feel to do things •
Ability to do day-to-day tasks •
My ability to get around •
How I feel about getting
around
•
Caring for myself • •
Treatment
Delivery (“How
Treatment Works”)
Dialysis/transplant going as
expected
•
Pills I have to take •
Providing my own treatment •
Ordering/storing supplies at
home
•
Fistula or catheter problems •
Finding a living donor •
Surgery for fistulas or
catheters
•
Blood tests, x-rays, and
doctor visits
•
Symptoms
(“Symptoms”)
Feeling tired • •
Thinking clearly • •
My memory • •
My attention • •
How well I can learn •
Itching, cramping, or aching • •
Table 1 Topics addressed in the decision aid (Continued)
Gaining weight •
Pain • •
Joint pain •
How healthy my body feels •
My energy • •
Cramps • •
Stomach problems • •
Bowel problems • •
Cough •
Trouble breathing • •
Skin problems •
Dry skin •
Changes in skin color •
How well I sleep •
How I feel about my looks • •
Relationships
(“Relationships”)
Family and friends need to
help
•
Making new friends •
Having and enjoying sexual
relations
• •
Sex drive • •
Orgasm problems •
Pain with sex •
Erection problems (Men) • •
Ejaculation problems (Men) •
Chances of having sex (Men) •
Trouble getting excited
(Women)
• •
Vaginal dryness (Women) • •
Psychological
(“Feelings”)
Feeling sad, anxious, or
stressed out
• •
Chances of being depressed • •
My nerves • •
My well-being • •
My emotions • •
My mood • •
How happy I am with my
life
• •
Finance (“Money
Matters”)
Money spent from own
pocket
•
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common patient experiences relevant to the “concerns.”
Video development stage 1: selecting patients and families
for the video, writing the script
Engaging a scriptwriter We engaged a professional
video scriptwriter with experience creating medical
education videos. The scriptwriter reviewed findings
from our foundational research and worked with our
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positive and negative viewpoints from patients and fam-
ilies about their chosen RRTs.
Selecting patients and families and writing the script.
We worked with local nephrologists in Baltimore, MD
to identify a diverse group of patients who might poten-
tially participate in the video. We asked nephrologists to
select patients receiving different forms of RRT with
specific demographic characteristics (e.g., minority female
who received a transplant) to ensure diversity. The script-
writer conducted 90 to 120 minute directed interviews
with patients and family members and recorded the con-
tent of interviews for review.
The scriptwriter then drafted a script by incorporating
views she obtained from patients and families. In our
previously conducted focus groups, patients and families
identified health care professionals they thought would
be appropriate to address various “concerns.” For ex-
ample, patients and family members felt physicians
would be appropriate for discussions about the health
risks and benefits associated with treatment selections,
while social workers would be more appropriate for dis-
cussing financial considerations. Our investigative team
reviewed the script and refined it to ensure all seven
“concerns” were adequately addressed by either patients
and families or health professionals (which included a
transplant nephrologist, transplant social worker, general
nephrologist, and dialysis social worker).
We also ensured that the video addressed complemen-
tary information to the handbook. Because the handbook
summarized findings from scientific studies about the
various RRT options (e.g., differences of health risks asso-
ciated with different therapies), we did not include this
type of quantitative information in the video (Table 1).
Video development stage 2: producing the video
Filming and producing the video A professional video
production crew filmed patients and family members in
their homes during scheduled visits. To obtain testimo-
nials on camera, an investigative team member inter-
viewed them using the same questions the scriptwriter
asked during initial directed interviews. The crew filmed
health care personnel in a studio. An investigative team
member asked health care providers questions to address
issues that patient testimonials did not already address.
After completing video filming and editing, we iteratively
refined the video, focusing on decreasing length and im-
proving clarity, consistency, and accuracy.
Video development stage 3: video screening and final edits
Screening groups Prior to final editing, we recruited
five patients receiving different RRTs from two local,academically affiliated nephrology practices in Baltimore,
MD and seven of the patients’ family members to screen
the video and provide their qualitative feedback during a
two hour group meeting led by a trained moderator.
The moderator elicited participants’ initial impressions
of the video as well as feedback regarding length,
amount of information presented, understandability, the
balance in presentation of positive and negative aspects
of the treatments, and areas for improvement. We
audio-recorded and transcribed screening group discus-
sions and we incorporated screening groups’ feedback in
our final iterations.
Methods: developing the handbook
The handbook complemented the video (Table 1) and
summarized findings from scientific studies about differ-
ences in patient-reported and clinical outcomes among
patients receiving different treatment options (in-center
hemodialysis, peritoneal dialysis, kidney transplantation,
and medical therapy with no dialysis or transplantation).
We also provided information about the methodological
quality of scientific studies. The handbook focused on
the same seven “concerns” highlighted in the video.
Handbook development stage 1: preliminary handbook
content design by our investigative team
We worked with specialists in medical illustration, adult
education, health communications, and in adapting
materials for low literacy readers to develop the hand-
book. We created several mock designs for presenting
information before conducting the pilot study.
Handbook development stage 2: mixed-methods pilot study
to guide iterative design
During early handbook development, we confronted
three main challenges, including (1) presenting informa-
tion about differences in multiple treatment types, (2)
presenting information quantifying the magnitude and
direction of scientific findings that did not incorporate
risk probabilities and could not be described using
standard methods (e.g. pictograms or bar graphs), [25]
and (3) communicating information to patients about
the quality of scientific evidence available to inform a
decision. [26] To help address these challenges, we per-
formed a pilot study among patients with kidney disease
to obtain their input on the clarity of information we
presented in various handbook iterations.
Pilot study goals, setting, and participants In two
study “phases,” we recruited a total of 48 English-speaking
patients from two local nephrology practices in the
Baltimore, MD metropolitan area to obtain qualitative
feedback on handbook material (Phase 1 and 2) and quan-
titatively test patients’ comprehension of handbook
Foundational Research 
Conducted 20 focus groups, a selective review of qualitative studies by other investigators, and systematic 
literature reviews to identify patients’ and families’ concerns and informational needs regarding renal
replacement therapy 
Video Development (17 total iterations) Handbook Development (26 total iterations)
Stage 1 (26 months, 11 script iterations)
Multidisciplinary team of experts developed a 
preliminary structure for the video and handbook 
to ensure their complementary nature and 
attention to seven key content areas 
Selected a diverse group of patients receiving 
different renal replacement therapies, their 
family members, and health care professionals
for potential participation in the video 
Conducted directed interviews to acquire patient 
and family member testimonials regarding their 
treatment experiences and draft an initial video 
script 
Stage 1 (12 months, 3 iterations)
Multidisciplinary team of experts developed a 
preliminary structure for the video and handbook to 
ensure their complementary nature and attention to 
seven key content areas 
Worked with a medical illustrator, adult education 
specialist, communications specialist, and a literacy 
expert to establish a preliminary standard format for 
presenting scientific information to patients 
Stage 2 (12 months, 3 video iterations)
Filmed patient, family member, and provider 
testimonials addressing seven key content areas 
Edited the video
Produced a video draft suitable for screening 
Stage 2 (15 months, 22 iterations )
Performed a two-phase mixed-methods study 
Phase 1, 16 iterations 
Conducted cognitive interviews with 12 patients to 
obtain critical feedback regarding the 
understandability of information presented and 
identify areas for improvement 
Phase 2, 6 iterations 
Performed an additional 36 cognitive interviews to 
obtain quantitative measures of comprehension and 
qualitative input on the presentation of information 
Stage 3 (4 months, 3 video iterations)
Screened a video draft to obtain qualitative 
feedback from patients and family members (12 
participants total)
Produced a final version of the video
Stage 3 (2 months, 1 iteration)
Screened a handbook draft to obtain qualitative 
feedback from patients and family members (12 
participants total)
Produced a final version of the handbook
Figure 1 Decision aid development process.
Ameling et al. BMC Medical Informatics and Decision Making 2012, 12:140 Page 5 of 13
http://www.biomedcentral.com/1472-6947/12/140material (Phase 2 only) during the iterative design process.
For both phases, we asked nephrologists to identify
patients either on dialysis or with progressive CKD (“Pre-
ESRD,” defined as estimated glomerular filtration rate of
less than 30 ml/min/1.73 m2) but not yet receiving dialysis
or a kidney transplant. We then approached patients to
assess their interest in participating in cognitive
interviews.
Phase 1 cognitive interviews During study Phase 1, we
performed cognitive interviews with 12 patients with
kidney disease to obtain feedback regarding the under-
standability of the information and ways to improve in-
formation presentation. We provided participants with a
binder that included 8 to14 sample handbook pages.
After participants reviewed each sample handbook page
a trained interviewer asked six open-ended questions: 1)
“Please tell me what you think the information on this
page means,” 2) “What does (fill in topic name) mean to
you?” 3) “We’re not sure if these are the best words touse, if you think there is a better way, we’d like to hear
it,” 4) “Is any part of this page unclear?” 5) “Do you have
any other suggestions?” and, 6) “On a scale of 1–5, with
1 being very hard to use and 5 being very easy to use,
how would you score your ability to use this picture and
the words to understand the information?” We audio-
recorded and transcribed each interview. We reviewed
transcriptions and made iterative changes to the hand-
book to address participants’ comments.
Phase 2 cognitive interviews and assessment of com-
prehension During study Phase 2, we performed 36
additional cognitive interviews. As with Phase 1, we
asked participants to provide qualitative feedback
regarding the understandability and usability of informa-
tion. In study Phase 2, we also assessed participants’
“gist” comprehension [27,28] of five key aspects of scien-
tific evidence presented on each page, including whether
they could understand: (1) the topic (“What issue are
we talking about on this page?”), (2) the treatment
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this page?”), (3) the direction of differences in outcomes
between RRTs being portrayed (“Which treatment is bet-
ter?”), (4) the magnitude of difference in outcomes be-
tween RRTs (“How much better or worse is one
treatment versus the other?”), and (5) the research qual-
ity of scientific studies to inform that aspect of the deci-
sion (“Does the page tell people how good the
information is?”).
We asked participants to view 7 to 9 different sample
handbook pages displaying similar types of information
(including information addressing five key aspects of scien-
tific evidence: topic, treatment modalities being compared,
direction of differences between treatments, magnitude of
differences, and research quality). We assessed participants’
gist comprehension of each key aspect on each page. Two
independent investigators reviewed transcripts of each
audio-recorded interview to assess participants’ gist com-
prehension and scored participants’ responses as correct or
incorrect. A third research team member adjudicated any
discrepancies among the two reviewers by also reviewing
the transcripts.
For each key aspect of scientific evidence, we calcu-
lated the number of pages for which participants cor-
rectly demonstrated comprehension. For example, if a
participant demonstrated correct comprehension of the
treatments displayed on 7 of 9 pages, we assessed that
participant as having correct comprehension of this
element 78% of the time. We then summarized the total
group’s comprehension of each element by calculating
the median (range) of all participants’ percentages indi-
cating correct comprehension of that element. We also
assessed patient participants’ demographic characteris-
tics; health literacy (Rapid Estimate of Adult Literacy in
Medicine) [29]; numeracy level (Risk Numeracy) [30];
cognitive function (Trails B) [31]; and knowledge and
awareness of kidney disease [7].
Handbook development stage 3: handbook screening and
final edits
Patients and family members who participated in the video
screening (described above under “Video Development,
Stage 3”) also reviewed the handbook and provided opi-
nions to the same open-ended questions.
Results
Feedback we received during each phase resulted in
numerous iterative refinements of both the video and the
handbook. We iteratively refined the video 17 times
(11 script iterations in Stage 1, three initial video iterations
in Stage 2, and three final film iterations in Stage 3). We it-
eratively refined the handbook 26 times (three iterations in
Stage 1, 22 iterations in Stage 2, and one final iteration in
Stage 3). Examples of preliminary handbook presentations,reflecting major iterative design approaches from Stages 1
and 2, are presented in Figure 2.
Results: findings from mixed methods pilot study
Of the 12 participants in pilot study Phase 1, 67% were
male, 92% were African American, and 75% had at most
a high school degree or GED. The majority of parti-
cipants were on hemodialysis (n=9, 75%), while the
remaining participants were classified as pre-ESRD (n=3,
25%). Of the 36 participants in Phase 2, 44% were male,
83% were African American, and 47% had at most a high
school degree or GED. Fifty-four percent of phase 2 par-
ticipants were on hemodialysis, 33% were considered
pre-ESRD, 29% on peritoneal dialysis, and 17% on home
hemodialysis. Participants in both phases were diverse
with respect to their knowledge of kidney disease, liter-
acy, numeracy, and cognitive function (Table 2).
Qualitative feedback obtained during cognitive inter-
views (during Phase 1 and Phase 2) focused on three key
areas: (1) difficulties identifying the multiple treatment
types presented in the handbook, (2) the handbook
containing an intimidating amount of complex scientific
information, and (3) their desires to have numerical
or quantitative information from scientific studies pre-
sented in a way that was clear and understandable.
Through a total of 22 iterations (16 iterations in Phase 1
and six iterations in Phase 2) we addressed these concerns
through numerous adjustments (including the use of color
coding to consistently identify RRT options when discussed
throughout the handbook, providing explanatory guides
for how to read pages, eliminating the use of abbreviations,
and supplementing graphical numerical presentations with
text written at a 4th to 6th grade reading level) (Table 3).
During study Phase 2, we measured gist comprehension
of materials among a total of 36 participants. Twenty-four
(24) participants provided feedback on iteration 20 of the
handbook and 12 participants provided feedback on
iteration 21 of the handbook. Among all items viewed by
participants, participants demonstrated median gist com-
prehension of 78% (range: 15%–100%) in iteration 20. Par-
ticipants’ median overall gist comprehension rose to a
median of 91% (range: 9%–100%) in iteration 21. Par-
ticipants demonstrated greatest gist comprehension on
aspects of pages reflecting the topic being discussed, the
treatment types (modalities) being compared, and the
direction of scientific findings discussing treatment differ-
ences (i.e., they could correctly identify one treatment was
better than the other). Participants demonstrated less gist
comprehension regarding the magnitude of treatment
differences (i.e., they had difficulty understanding how
much better one treatment was than another) and infor-
mation about the research study quality. However, gist
comprehension scores improved in these areas between
iterations 20 and 21 (Table 4).
Figure 2 Representative sample iterations from stages 1 and 2 of the handbook development process.
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Five patients and seven family members participated in
two different screening groups. Patient participants were
80% female, 60% African American, and 60% had at least
two years of college education. All family member parti-
cipants were female, 71% were African American, and
43% had at least two years of college education.
Patients and family members provided mostly positive
feedback after screening both the video and handbook.
(Table 5) Participants often commented that they liked
the organization of the video and the breadth of topics it
covered. Participants also commented on the comple-
mentary nature of the two materials. Screening group
participants constructively criticized the large amount of
information presented in the handbook. To address this
concern, we created a mini-book entitled, “All of the
Facts,” to accompany the handbook, which provides
readers with a brief summary of key information pre-
sented in the longer handbook.
Results: final decision Aid
The final decision aid consists of a 50-minute video and
a comprehensive, 159-page handbook accompanied by a
14-page mini-book (“All of the Facts”) which sum-
marizes the key information in the handbook. Together,
the video and handbook satisfied 92% of all qualitycriteria outlined in the three subject areas designated by
IPDAS (satisfied 96% or 22 of 23 content items, 87% or
20 of 23 development process items, and 100% or 6 of 6
effectiveness items) (Additional file 1).
The video provides testimonials from minority and
non-minority (male and female) patients, their family
members, and health care professionals (physicians and
social workers) about “concerns” patients and their
families might have which could influence their RRT
selection decisions. These “concerns” correspond to the
seven key content areas patients and their families iden-
tified as important to include in the decision aid during
our foundational research studies. Patients and family
members receiving different RRTs share subjective testi-
monials describing their positive and negative experi-
ences with these “concerns” in the video. Health care
providers discuss additional information regarding “con-
cerns” to balance patient and family views and to con-
tribute additional information.
The handbook provides evidence-based information
regarding risks and benefits of different treatment options
of peritoneal dialysis, in-center hemodialysis, home
hemodialysis, kidney transplant, and conservative manage-
ment (treatment with no transplant or dialysis) as they
pertain to these same patient concerns. The introduction
includes a section that defines kidney disease (“What Is
Table 2 Participant characteristics for handbook
development Stage 2 (Phases 1 and 2)
Patient
characteristics,
n(%)
All participants
(Phases 1 & 2)
Phase 1
participants
Phase 2
participants
(n=48) (n=12) (n=36)
Age
Mean [Range] 59 [33–85] 58 [46–71] 60 [33–85]
Gender
Male 24 [50%] 8 [67%] 16 [44%]
Race/Ethnicity
African American 41 [85%] 11 [92%] 30 [83%]
non-African
American
7 [15%] 1 [8%] 6 [17%]
Education
Less than a high
school degree
9 [19%] 4 [33%] 5 [14%]
High school
degree/GED
17 [35%] 5 [42%] 12 [33%]
Some college 14 [29%] 3 [25%] 11 [31%]
Bachelor’s degree 6 [13%] 0 [0%] 6 [17%]
Graduate or
professional school
2 [4%] 0 [0%] 2 [5%]
Treatment Group
Pre-ESRD 15 [31%] 3 [25%] 12 [33%]
Hemodialysis 22 [46%] 9 [75%] 13 [54%]
Home Hemodialysis 4 [8%] — 4 [17%]
Peritoneal Dialysis 7 [15%] — 7 [29%]
Knowledge of
Kidney Disease§
Extensive
knowledge
4 [8%] 1 [8%] 3 [8%]
A great deal of
knowledge
20 [42%] 4 [33%] 16 [44%]
Some knowledge 18 [38%] 7 [59%] 11 [31%]
Limited to no
knowledge
5 [10%] 0 [0%] 5 [14%]
Don’t know 1 [2%] 0 [0%] 1 [3%]
Literacy
3rd grade and
below
5 [10%] 1 [8%] 5 [14%]
4th to 6th grade 4 [8%] 2 [17%] 2 [5%]
7th to 8th grade 14 [29%] 6 [50%] 8 [22%]
9th grade and
above
25 [52%] 3 [25%] 22 [61%]
Numeracy
Risk numerate€ 14 [30%] 3 [25%] 11 [31%]
Cognition¥
Cognitive
impairment
10 [21%] 3 [25%] 7 [19%]
§ Based on self-report.
¥ Time of 273 seconds or longer indicates a cognitive deficiency, 2 participants
missing data from Phase 2.
€Considered risk numerate if 3 of 3 risk numeracy questions answered
correctly, 1 participant missing from Phase 2.
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treatment options (“What are the Treatments?”), presents
a value clarification exercise to help patients determine
which treatment is best for them (“How Do I Choose a
Treatment?”), and orients the reader to the page layout
(“What is on Each Page?”). Subsequent sections of
the handbook describe summaries of scientific studies
relevant to each “concern.” Handbook pages are 8.5” by
11” and oriented toward a 4th to 6th grade reading level.
The handbook delivers content on a double-page spread
layout to appeal to diverse learning preferences: the left-
hand page includes brief statements summarizing key
messages from scientific studies while each right-hand
page presents a more detailed summary of study findings
and a graphical presentation of data (Figure 3).
Discussion
Patients need high quality decision aids to help guide
them through the decision-making process about RRT
selection. To our knowledge, rigorous and systematic
approaches to developing decision aids for patients with
CKD have not been previously undertaken. We devel-
oped our decision aid to accommodate patients with
varying literacy, numeracy, and cognitive needs. The
final decision aid achieved the vast majority of IPDAS
criteria for engaging patients in informed decision-mak-
ing. Our refinement process incorporated 11 video script
iterations and 26 handbook iterations, reflecting the
extensive effort we undertook to develop materials that
addressed patients’ self-reported informational needs.
Initial screening of our decision aid by patients and their
families indicates that these materials are likely to be
well received. Pilot testing in our mixed-methods study
suggested patients found the final handbook understand-
able. However, further testing is still needed to deter-
mine how effective or useful the decision aid is for
ESRD patients’ treatment decisions.
Our development process and findings highlight some
of the challenges of developing comprehensive materials
for a diverse population that address the positive and
negative features of various RRT options. First, we based
our content on rigorous foundational studies (20 focus
groups and systematic literature reviews), which required
substantial time and effort to conduct. Translating our
findings from these studies to inform decision aid devel-
opment also proved challenging as we sought to address
multiple concerns identified by patients and invested
additional significant time and effort performing the
mixed-methods pilot study to identify ways to convey
scientific information in a way that can be easily inter-
preted by the vast majority of patients. Further, factors
such as the layout of information and the inclusion of
figures are known to be potential sources of bias in deci-
sion making. For instance, the final handbook (150 pages)
Table 3 Qualitative feedback from handbook development Stage 2 (Phases 1 and 2)
Patient concerns Representative quotes Specific challenges
encountered
Solutions
Patients did not know
their treatment options
“First, can you explain the two treatments?
What is the difference between those two
treatments?”
• Defining patients’ various
treatment options
• Added a treatment definition page (“What
are the Treatments?”)
• Replaced all abbreviations with actual
treatment names
• Making complex medical
terminology memorable
• Color-coded each treatment option
• Associated each treatment with its own icon
Intimidating amount of
complex information
“And I just feel like this is so much
information that's written that is not
going to be taken in.”
• Translating research
evidence into plain language
• Developed a question and answer format in
plain language
• Revised the language in the to achieve a
fourth grade reading level
• Created a new section (“What is on Each
Page?”) to introduce and define research
quality
• Communicating research
quality
• Used pictures of “real” doctors and patients
diverse in age, sex, and gender
• Placed tabs throughout the handbook to
divide it into smaller sections
• Making the handbook user-
friendly
• Added an interactive value clarification
exercise (“How Do I Choose a Treatment?”)
Understanding numerical
information or statistical
concepts
“I don’t want these chances or things. . .it’s
real confusing. I want to know the facts.”
• Presenting graphical
illustrations of data
• Used graphical presentations patients
responded to most positively
• Supplemented graphical presentations with
text to reiterate the intended message
• Adopted a double page spread format to
appeal to a diverse group of readers
• Using both positive and
negative framing of statistical
information
• Used an example study to anchor each
head-to-head treatment comparison
• Explaining effect size • Modified effect size terminology from a
“small/medium/large amount” to “a little/
somewhat/ a lot better”
Table 4 Median percentage** of times participants
correctly comprehended key aspects of scientific
evidence during pilot testing (handbook development
Stage 2, Phase 2)
Key aspects of
scientific evidence*
Iteration 20 Iteration 21
(n=24) (n=12)
Topic 100% [22%–100%] 100% [0%–100%]
Treatment Modality 100% [33%–100%] 100% [29%–100%]
Direction of Difference 89% [22%–100%] 86% [14%–100%]
Magnitude of Difference 71% [0%–100%] 100% [0%–100%]
Research Quality 56% [0%–100%] 100% [0%–100%]
Total: All Items 78% [16%–100%] 91% [9%–100%]
*Correct identification of five key items shown as a median percentage.
followed by the respective range.
**Ranges in the table represent [minimum-maximum] values.
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create a shorter “All the Facts” 14-page handbook in
response to participants’ comments during the screening
sessions, we did not formally compare how participants
viewed this distilled version of information compared to
the complete handbook and video. Further testing will
help clarify the optimum format for information. We are
currently studying these materials in a randomized con-
trolled trial to examine their influence on treatment deci-
sions in African Americans [32], and we are designing
additional studies to help further refine the decision aid.
Incorporating subjective testimonials about treatment
could introduce bias as patients may identify with video
participants rather than synthesize information on pre-
ference sensitive topics. [33-35] Nonetheless, treatments
for ESRD are quite complex, requiring many practical
considerations that significantly alter patients’ daily lives.
We therefore felt it was very important to show viewers
examples of patients and families undergoing these
treatments. For instance, our video shows a patient who
receives home hemodialysis inserting a needle into hisdialysis fistula. It shows another patient receiving
hemodialysis in a treatment unit, and yet another patient
administering peritoneal dialysis in her home with help
from her spouse. The video depicts patients storing
boxes of treatment supplies, handling medications, and
Table 5 Positive and constructive feedback obtained from screening the decision aid
Reactions Video Handbook
Positive feedback Constructive feedback Positive feedback Constructive feedback
Overall
Impression
“. . . if it was something like that
available. . .when I started
dialysis it would have really
been welcome because
information was
scattered. . .And this, I like the
way it’s organized, the way it’s
broken down. . . I think it’s
touched just about on
everything that your initial
concerns would be.”
“What I did have an issue with
was the sequence of, I liked the
way everything was broken
down but I think it should have
been sequenced differently
starting with dialysis at the
center, because they said that
was what’s most frequently
done, most frequently used.”
“I really do love this book. It
does give a whole lot of
information for someone who’s
just starting out. You know,
they really need all of the
information they can-that they
can get. And I love the fact that
they would have a DVD to go
along with it.”
“A lot of times if a person is just
starting dialysis, you know, you
got the sluggishness in your
brain, your memory, and your
attention. And it might be a
little hard to focus on this as
opposed to seeing a film,
hearing people’s testimonies,
you know, I think that would
settle a little better than, you
know, trying to absorb all of
this.”
Length “But I didn’t mind the length of
it because it gave, you know,
information that you need to
know.”
“I thought it was too long. But
as it went on we could see
how important it was for it to
be that long and I think if I was
in that situation, it might not
have been that long but since
it wasn’t my issue, too long.”
“When I first saw it, it felt
overwhelming but it was
broken down so well that I can
just go to the parts that I think
are relevant to myself or that I
want to see that day. . . it's
separated so well that I can just
go and look at it.”
“I mean, the inside of it, the
content is good. I like the
graphics in it and the
charts. . .but I guess if it was
some kind of way you could
kind of condense it because
they’re probably already getting
a whole lot of other information
at the same time to have to
carry a big book.”
Amount of
Information
“I think it's very informative and
has just the right amount of
information.”
Constructive feedback not
available
“I think this is a terrific
reinforcing publication plus
when you’re watching a film
you can only remember so
much whereas you’re going to
go back here and you’re going
to see all of it in the different
forms. . . Reading and writing
solidify your thinking. . .I like it.”
“It could be very daunting just
even looking at it. But if you
have a video hopefully it will
pique your interest enough to
be able to go to the individual
area that you’re concerned with
and get that information that
you need.”
Easy to
Understand
“I did learn a lot of information
from watching the movie. Even
having some relatives that had
kidney issues, this still provided
more information.”
Constructive feedback not
available
“It’s doesn’t go to a junior high
school level so that means that
everybody can understand it.
So yeah I think it's clear.”
“The spoken word, a lot of
times, is much easier. I think the
combination is a great vehicle, I
do. But I think with this, you
know, that’s one of the things
that I’d be concerned about.
‘Cause someone with a fifth
grade reading level wouldn’t
really be able to understand
everything.”
Balanced
Presentation
of Treatment
Options
“I don’t think they leaned
anywhere. In fact, they kept
saying basically it was your
options to select or decide
which way you want to go and
you even had an option to
rescind that and go in another
direction.”
Constructive feedback not
available
“Yeah it's pretty well balanced
because it has the section for
each treatment, you know,
each mode in there so it's
balanced.”
Constructive feedback not
available
Areas of
Improvement
Not applicable “I think the one improvement
that I would suggest is that
[they put] a little bit more
emphasis in each type of
treatment about the emotional
impact on not just you but also
your family and your support
system.”
Not applicable “I think the best part and most
useful part for most of the
population is the all the facts
part. It’s nice how they’ve
compared the transplant, which
is the ideal, to the other
treatments. It might be helpful
if there were a foldout where all
the treatments were laid out
like this to just read across.”
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visualization, many patients considering these treat-
ments may not fully comprehend the significant
differences between therapies. Future studies will be
needed to assess whether viewers of our video felt com-
pelled to choose a treatment because of their subjective
identification with video participants.
Some additional limitations of our process are import-
ant to consider. Although our team comprised experts
from multiple disciplines, it did not include a decision
scientist, which may have influenced our development
approach. We did, however, refer to the decision sciences
literature extensively as well as the IPDAS criteria through-
out the development process [19,25-28,36-40]. We also
developed our decision aid with input from a largely
minority (African American) population of patients with
kidney disease living in the Baltimore, MD metropolitan
area. It is possible patients with different characteristics
could have different viewpoints about RRT which might
have altered our development process. Further, we devel-
oped our decision aid for English-speaking patients. Mate-
rials may require significant adaptation to accommodate
reading and cultural needs of non-English speakers.
Conclusion
We developed a decision aid to help patients with kid-
ney disease and their families make informed decisions
about RRT selections aligned with their values. While
our development process helped to ensure completeness
and readability of our decision aid, its effectiveness on
aiding patients’ treatment decisions warrants further
study.
Additional file
Additional file 1: IPDAS criteria met by video and handbook
decision aid.
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